Locations:
Search
First-ever transcarotid artery revascularization trial with no strokes or device-related deaths
Consensus statement outlines the team, infrastructure and experience needed to deliver TTVI safely and effectively
Innovative approach to living-tissue AVR achieves low reintervention rates, excellent long-term survival
Diagnosis and treatment of malnutrition and cachexia are key to improving cardiac outcomes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Symptom burden at presentation is a potent predictor of long-term survival, large analysis shows
New framework better distinguishes stable from critically ill patients
CMR-CLIP outperforms general AI tools; may one day expand patient access to CMR
Post hoc analysis of CLEAR Outcomes trial bolsters its case as a statin alternative
Large retrospective analysis may prompt prospective studies
How to talk about lifetime risk, treatment goals, Lp(a) testing, statin skepticism and more
Advertisement
Advertisement